. Prospects for the Development of Pink1 and Parkin Activators for the Treatment of Parkinson's Disease. Pharmaceutics. 2022 Nov 19;14(11) PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.